Please use this identifier to cite or link to this item: http://repository.ipb.ac.id/handle/123456789/155557
Full metadata record
DC FieldValueLanguage
dc.contributor.advisorAlimuddin
dc.contributor.advisorSoelistyowati, Dinar Tri
dc.contributor.authorOktapiani, Kelara
dc.date.accessioned2024-08-04T02:48:37Z
dc.date.available2024-08-04T02:48:37Z
dc.date.issued2024
dc.identifier.urihttp://repository.ipb.ac.id/handle/123456789/155557
dc.description.abstractSalah satu kendala yang sering terjadi dalam budidaya ikan nila adalah penyakit bakterial yang disebabkan oleh bakteri Aeromonas hydrophila. Usaha yang dapat dilakukan untuk mengurangi dampak infeksi bakteri patogen adalah dengan melakukan evaluasi respons imun secara molekuler. Penelitian ini bertujuan untuk mengevaluasi respons imun ikan nila (Oreochromis niloticus) terhadap infeksi bakteri A. hydrophila berdasarkan ekspresi gen mhc1, lisozim (lysc), dan interleukin (il1b) serta gambaran darah di jaringan hati ikan pascainfeksi. Perlakuan infeksi diberikan melalui penyuntikan ikan nila dengan 0,1 mL bakteri A. hydrophila dosis LD50 secara intramuskular, dan pada ikan kontrol dilakukan penyuntikan dengan 0,1 mL PBS. Selanjutnya dilakukan isolasi jaringan, analisis darah, ekstraksi RNA dan sintesis cDNA, serta analisis ekspresi gen. Hasil penelitian menunjukkan pada ikan yang diinfeksi A. hydrophila memiliki tingkat kelangsungan hidup sebesar 21,42%, sedangkan pada ikan kontrol tidak ditemukan kematian. Ekspresi gen mhc1,lysc dan il1b ikan nila resistan cenderung lebih tinggi daripada ikan nila yang rentan pascainfeksi A. hydrophila. Gambaran darah yang meliputi hematokrit, jumlah eritrosit, leukosit dan kadar hemoglobin pada ikan nila tahan infeksi (resistan) A. hydrophila menunjukkan kecenderungan lebih tinggi dibandingkan dengan ikan nila yang tidak tahan infeksi (rentan).
dc.description.abstractOne of the obstacles that often occurs in tilapia cultivation is bacterial disease caused by the bacteria Aeromonas hydrophila. Efforts that can be made to reduce the impact of pathogenic bacterial infections include conducting a molecular evaluation of the immune response. This study aims to evaluate the immune response of tilapia (Oreochromis niloticus) to A. hydrophila infection based the expression of mhc1, lysozyme (lysc), and interleukin (il1b) genes and on blood profiles in the liver tissue after infection. Infection treatment was given by injecting tilapia fish with 0.1 mL of the LD50 dose of A. hydrophila bacteria intramuscularly, and control fish were injected with 0.1 mL of PBS. Then, tissue isolation, blood analysis, RNA extraction, cDNA synthesis, and gene expression analysis were carried out. The results of the study showed that fish infected with A. hydrophila had a survival rate of 21.42%, while no deaths were found in control fish. The expression of the mhc1, lysc, and il1b genes in resistant tilapia tended to be higher than in susceptible fish after A. hydrophila infection. Blood profiles including hematocrit, number of erythrocytes, leukocytes, and hemoglobin levels in resistant tilapia to A. hydrophila infection tends to have higher level compared to susceptible fish.
dc.description.sponsorship
dc.language.isoid
dc.publisherIPB Universityid
dc.titleEkspresi Gen dan Gambaran Darah Ikan Nila (Oreochromis niloticus) Tahan Infeksi Aeromonas hydrophilaid
dc.title.alternativeGene Expression and Blood Profiles of Nile Tilapia (Oreochromis niloticus) Resistant to Aeromonas hydrophila
dc.typeSkripsi
dc.subject.keywordAeromonas hydrophilaid
dc.subject.keywordOreochromis niloticusid
dc.subject.keywordil1bid
dc.subject.keywordlyscid
Appears in Collections:UT - Aquaculture

Files in This Item:
File Description SizeFormat 
cover_C14180033_6592f928fc7a4d3bb1bcebfc7d3fa252.pdfCover492.67 kBAdobe PDFView/Open
fulltext_C14180033_da3e7902614e4ba3bf8a0e0eac4f20ed.pdf
  Restricted Access
Fulltext715.63 kBAdobe PDFView/Open
lampiran_C14180033_8d6e3c29acab4118a32f253897e1af41.pdf
  Restricted Access
Lampiran232.43 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.